Search results

Jump to navigation Jump to search
  • ...nal |author=Fritz E, Ludwig H, Scheithauer W, Sinzinger H |title=Shortened platelet half-life in multiple myeloma |journal=Blood |volume=68 |issue=2 |pages=514 ...s Disease. The chronic form in adults is usually caused by antibodies to [[Platelet glycoprotein GPIIb-IIIa complex]] or Ib-IX.<ref name="isbn0-7216-0187-1"/>
    4 KB (579 words) - 13:26, 23 November 2010
  • .../> This leaves vasoconstriction, platelet aggregation, and thrombosis from platelet thromboxane A2 mediated by COX-1 intact.<ref name="pmid-16968830"/>
    2 KB (265 words) - 09:16, 28 December 2010
  • {{r|Platelet}}
    588 bytes (71 words) - 16:58, 11 January 2010
  • {{r|Platelet}}
    619 bytes (80 words) - 21:25, 11 January 2010
  • {{r|Platelet}}
    610 bytes (73 words) - 15:48, 11 January 2010
  • {{r|Platelet}}
    651 bytes (80 words) - 10:59, 11 January 2010
  • {{r|Platelet}}
    679 bytes (85 words) - 15:36, 11 January 2010
  • ...actor complex. The von Willebrand factor has receptors for [[collagen]], [[platelet]]s, and [[ristocetin]] activity as well as the immunologically distinct ant
    629 bytes (86 words) - 17:31, 10 July 2010
  • {{r|Platelet}}
    834 bytes (105 words) - 19:56, 11 January 2010
  • {{r|Platelet}}
    759 bytes (101 words) - 15:55, 11 January 2010
  • ...'''cangrelor''' is an [[purinergic P2Y receptor antagonist]]s that is a [[platelet aggregation inhibitor]]. ...Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW et al.| title=Effect of platelet inhibition with cangrelor during PCI on ischemic events. | journal=N Engl J
    6 KB (873 words) - 12:25, 27 August 2013
  • {{r|Platelet}}
    828 bytes (107 words) - 22:30, 17 April 2011
  • {{r|Platelet transfusion}}
    816 bytes (122 words) - 01:41, 15 November 2010
  • ...antagonize or impair any mechanism leading to blood [[platelet activation|platelet aggregation]], whether during the phases of activation and shape change or Inhibitors of the [[platelet glycoprotein GPIIb-IIIa complex]] (GPIs) include the [[monoclonal antibody]
    4 KB (543 words) - 01:43, 8 May 2013
  • {{r|Platelet}}
    1 KB (147 words) - 07:44, 8 January 2010
  • {{r|Platelet}}
    1 KB (146 words) - 21:45, 23 August 2010
  • ==Anatomy of a platelet== ...brand factor]]), the contents of which are released upon activation of the platelet. These granule contents play an important role in both [[hemostasis]] and i
    12 KB (1,658 words) - 08:52, 28 June 2011
  • ...nce of [[fibrin]] strands following the mixing of plasma with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of t
    1 KB (155 words) - 10:43, 23 August 2010
  • ...nism of [[phagocytosis]]. They produce [[leukotriene]] C<sub>4</sub> and [[platelet activation factor]] (PAF). <ref name=Ganong>{{citation ...Ganong, p. 508</ref> Especially infectious parasites produce inhibitors of platelet aggregation.<ref name=Liu>{{citation
    4 KB (579 words) - 22:42, 9 June 2010
  • ...of [[hematoepoesis]]: generation of [[erythrocyte]]s, [[leukocyte]]s and [[platelet]]s from [[hematopoetic stem cell]]s.
    1 KB (202 words) - 20:28, 25 June 2010
View ( | ) (20 | 50 | 100 | 250 | 500)